• Clinical Trial of Potential CAR T-cell Therapy for Advanced Multiple Myeloma to Open in US
    Janssen recently initiated a Phase 1b/2 clinical development program to evaluate JNJ-68284528, a chimeric antigen receptor (CAR) T-cell therapy, as a possible treatment of relapsed or refractory multiple myeloma.

  • Harnessing ‘rogue’ stem cells to grow healthy fat could help treat metabolic disorders
    One theory of obesity suggests that when the body loses the ability to make healthy brown fat, unhealthy white fat cells expand and build up around the body, leading to heart disease and other adverse effects of being overweight.

  • RA Drug May Reduce Toxicity Caused By CAR T Treatment
    While the development of chimeric antigen receptors (CAR) T-cell therapy has changed the landscape of cancer treatment and was named “Advance of the Year” by the American Society of Clinical Oncology for 2018

  • US FDA approves Cellectis’ third ‘off-the-shelf’ CAR T-cell candidate for clinical trials
    The FDA approved an investigational new drug application from Cellectis for a Phase 1 clinical trial of UCART22, its third gene-edited CAR-T cell candidate.

  • The 3rd National Festival and International Congress on Stem Cells and Regenerative Medicine
    Considerable advances in Stem Cells and Regenerative Medicine during the past decade, has created much hope for the treatment of chronic and incurable illnesses, such as various cancers, genetic illnesses, illnesses due to old age, and deterioration of tissues and organs

 

 

 

Vice-presidency News
Visit of the first technology development center of advanced embryo cell products
The vice president for science and technology affairs visited the first technology development center of advanced embryo cell products with the goal of supporting technological projects in the area of cells and molecules.
 14:20 - 10/06/2018 - Comments : 0More >>
Test implementation standards in the section of laboratory services will be presented to users
The manager of strategic technologies laboratory network stated: in the laboratory services section, test implementation standards and search of tests related to products will be presented to users.
 13:30 - 05/05/2018 - Comments : 0More >>
World News
Clinical Trial of Potential CAR T-cell Therapy for Advanced Multiple Myeloma to Open in US
Janssen recently initiated a Phase 1b/2 clinical development program to evaluate JNJ-68284528, a chimeric antigen receptor (CAR) T-cell therapy, as a possible treatment of relapsed or refractory multiple myeloma.
 08:48 - 20/06/2018 - Comments : 0More >>
Harnessing ‘rogue’ stem cells to grow healthy fat could help treat metabolic disorders
One theory of obesity suggests that when the body loses the ability to make healthy brown fat, unhealthy white fat cells expand and build up around the body, leading to heart disease and other adverse effects of being overweight.
 08:45 - 20/06/2018 - Comments : 0More >>
Council News
Announcing the 3rd National Festival and International Congress on Stem cells and Regenerative Medicine in the Science Events section of the ISSCR website
According to the Public Relations and International Affairs of the council for Stem cell science and technology for Stem Cells, holding of the "Third National festival and International Congress on Stem cells and regenerative medicine was informed in the Scientific Events section of the website: (ISSCR) The International Society for Stem Cell Research.
 14:30 - 10/06/2018 - Comments : 0More >>
The greatest gathering of national stem cell activists
The executive secretary of 3th national and international congress on the stem cell and regenerative medicine said it is essential that the Islamic Republic of Iran as the country which is moving at the borders of science and technology of the stem cells save its own excellence with holding the annual national festival in this strategic field.
 12:33 - 30/05/2018 - Comments : 0More >>
National News
The Leader picks “Support for Iranian Products” as New Year’s motto:
All must work to realize this year’s motto
In a message marking the arrival of the Solar calendar year of 1397 (beginning March 21, 2018), Leader of the Islamic Revolution Ayatollah Seyyed Ali Khamenei congratulated all Iranian compatriots, particularly the respectable families of martyrs and the war-wounded as well as promising youths and teenagers, who are the driving force behind the country’s scientific movement.
 11:45 - 07/04/2018 - Comments : 0More >>
President Hassan Rouhani:
Great Steps Have Been Taken in Various Fields During Last Year
President Rouhani described year 1396 as the year of success for the great Iranian nation in various fields despite the wish of the enemies and said: “The unity among the Iranian nation has surprised all enemies and they admitted to the greatness of our people”.
 11:38 - 07/04/2018 - Comments : 0More >>